While the expression of the DNMT3b-related aberrant DNA hypermethylation among basal-like breast cancers is now well established, the molecular mechanism governing the hyper methylation defect has not been examined in primary breast cancer. This evidence concerns the gene DNMT3B and breast carcinoma.